Histiocytic neoplasms are a group of rare blood diseases caused by an overproduction of the white blood cells called histiocytes, causing tissue damage or the formation of tumors.
Histiocytic neoplasms include Erdheim-Chester disease, Rosai-Dorfman disease, and Langerhans cell histiocytosis.
Cotellic (cobimetinib) is the first FDA approved treatment for all forms of histiocytic neoplasms.
Drugs used to treat Histiocytic Neoplasm
| Name | Drug Class |
|---|---|
| Cobimetinib | Multikinase inhibitors |
| Cotellic | Multikinase inhibitors |
